| Model ID | 12-034-02 |
| Model Name | Wang 2012 - 1 Year Imminent Death |
| Pubmed ID | 22819429 |
| First Author | Wang |
| Journal | American Journal of Cardiology |
| Year | 2012 |
| Title | Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration |
| Primary Index Condition | Chronic Heart Failure (CHF) |
| Secondary Index Condition | N/A |
| Outcome | Mortality |
| Model Sample Size | 198640 |
| Cohort Sample Size | 198640 |
| Number of Events | 14103 |
| Follow-Up Duration | Long (>6 months) |
| AUROC | 0.758 |
| Calibration Reported | 1 |
| Covariates | Age (years) 18-55; Age (years) 55-65; Age (years) 65-75; Age (years) 75-80; Age (years) 80-85; Age (years) >85; Male vs female; Married currently; Service connection >=50% vs <50%; VA priority groups 1 vs 6 to 8; VA priority groups 2,3 vs 6 to 8; VA priority groups 4 vs 6 to 8; VA priority groups 5 vs 6 to 8; Age >=65 years; Deyo-Charlson Index; Age 65 * Deyo-Charlson; Myocardial infarction (MI); CABG; MI * CABG; Unstable angina pectoris; Respiratory failure; Valvular heart disease; Respiratory failure * valvular heart disease; Renal failure; Chronic obstructive pulmonary diseases (COPD); Renal failure * COPD; Dementia; Renal failure * dementia; Hospitalized in the prior year; Hospitalized * valvular heart disease; Stroke; Hospitalized * stroke; Renal failure * stroke; Function disease; COPD * dementia; Pneumonia; Diabetes; Malnutrition; Peripheral vascular disease; Metastatic cancer; Trauma; Hospitalized * trauma; Psychotic disorder; Liver disease; Atrial fibrillation; Mental disorder; Systolic blood pressure 110-140 vs <110; Systolic blood pressure >140 vs <110; Diastolic blood pressure 60-89 vs <60; Diastolic blood pressure >=90 vs <60; Heart rate 60-85 vs <60; Heart rate >85 vs <60; Respiration 18-20 vs <18; Respiration >20 vs <18; Body mass index (BMI) 25-29 vs <25; BMI 29-35 vs <25; BMI 35+ vs <25; BMI missing vs <25; Emergency visits (1 year): 1 vs 0; Emergency visits (1 year): 2 vs 0; Emergency visits (1 year): 3,4 vs 0; Emergency visits (1 year): 5+ vs 0; Primary care visits (1 year): 1,2 vs 0; Primary care visits (1 year): 3,4 vs 0; Primary care visits (1 year): 5+ vs 0; Cardiology visits (1 year): 1+ vs 0; Pulmonary visits (1 year): 1+ vs 0; Mental health visits (1 year): 1-3 vs 0; Mental health visits (1 year): 4+ vs 0; Phone visits (1 year): 1-3 vs 0; Phone visits (1 year): 4+ vs 0; Other nonface visits (1 year): 1,2 vs 0; Other nonface visits (1 year): 3-9 vs 0; Other nonface visits (1 year): 10-15 vs 0; Other nonface visits (1 year): 16+ vs 0; Other visits (1 year): 1-3 vs 0; Other visits (1 year): 4-9 vs 0; Other visits (1 year): 10-29 vs 0; Other visits (1 year): 30+ vs 0; Outpatient visits (1 year): 6-10 vs 0-5; Outpatient visits (1 year): 11-19 vs 0-5; Outpatient visits (1 year): 20-29 vs 0-5; Outpatient visits (1 year): 30+ vs 0-5; Emergency visits (1 month): 1+ vs 0; Cardiology visits (1 month): 1+ vs 0; Other nonface (1 month): 1 vs 0; Other nonface (1 month): 2+ vs 0; Other visits (1 month): 1 vs 0; Other visits (1 month): 2+ vs 0; Outpatient visits (1 month): 1 vs 0; Outpatient visits (1 month): 2 vs 0; Outpatient visits (1 month): 3+ vs 0; Mental health hospitalizations (1 year): 1+ vs 0; All hospitalizations (1 year): 1 vs 0; All hospitalizations (1 year): 2 vs 0; All hospitalizations (1 year): 3 vs 0; All hospitalizations (1 year): 4 vs 0; All hospitalizations (1 year): 5+ vs 0; Number providers: 2 vs 1; Number providers: 3,4 vs 1; Number providers: 5,6 vs 1; Number providers: 7+ vs 1; Number of refills: 1-14 vs 0; Number of refills: 15-22 vs 0; Number of refills: 23-31 vs 0; Number of refills: 32-45 vs 0; Number of refills: 46+ vs 0; ACEI/ARB; Hospitalized * ACEI/ARB; Alpha-blockers; Anticholinergics; Antidepressants; Antipsychotics; Benzodiazepines; Beta agonists; Beta blockers; Hospitalized * Beta blockers; Bumetanide; Digoxin; Furosemide; Statins; Insulin; Metformin; Metolazone; Hospitalized * metolazone; Nitrates; Opioid narcotics; Hospitalized * opioid narcotics; Age 65 * opioid narcotics; Non-steroidal anti-inflammatory drugs (NSAID); Age 65 * NSAID; Thiazolidenediones; Potassium-sparing diuretic; Oral steroids; Diuretic combinations; Torsemide; Warfarin; No laboratory test in last year; Albumin (g/dL): 2.5-3.5 vs >=3.5; Albumin (g/dL): <2.5 vs >=3.5; Albumin not tested vs >=3.5; Blood urea nitrogen (mg/dL): 17-25 vs <17; Blood urea nitrogen (mg/dL): 25-40 vs <17; Blood urea nitrogen (mg/dL): >40 vs <17; Blood urea nitrogen not tested vs. <17; Creatinine (mg/dL): 1.2-2 vs <1.2; Creatinine (mg/ |
| Mesh Terms | To be updated |
| Number of Validations | 0 |
